#Venture Capital
Omaas Therapeutics lands $310 million Series C to push forward small‑molecule endocrine and immunology drugs
The biotech raised $310 million in a Series C financing, taking its valuation to $1.2 billion as it expands its small‑molecule pipeline in endocrinology and immunology.